Loading provider…
Loading provider…
Dermatology Physician in Lenexa, KS
NPI: 1275700528Primary Practice Location
Mawd Pathology Group PA
9705 Lenexa Dr, Lenexa, KS
Primary Employer
Derm Hair Center
dermhaircenter.org
HQ Phone
Get MD Meena's Phone Numberphone_androidMobile
Get MD Meena's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 17311Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | 273 | 340 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 135 | 182 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 128 | 148 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 125 | 131 |
| 5 | 13132Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 110 | 123 |
Authors: Marc Avram
Journal: J Clin Aesthet Dermatol
Technical considerations for follicular unit extraction in African-American hair.
Authors: Singh, Meena K, Avram, Marc R
Journal: Dermatol Surg
Publication Date: 2013-05-13
A cytomics-on-a-chip platform and diagnostic model stratifies risk for oral lichenoid conditions.
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Lebrikizumab
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: BIOLOGICAL: Lebrikizumab